L

    Longeveron LLC (LGVN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.90
    +0.18 (+2.68%)

    Market Cap: $21.42M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    37%(7/19)
    Avg Surprise
    -8.84%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.70
    Range$-2.20 - $-1.00
    4 analysts
    EPS Revisions
    1
    0
    7d
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-1.50+11.8%
    60d ago$-1.50+11.8%
    30d ago$-1.50+11.8%
    7d ago$-1.50+11.8%
    Current$-1.70
    Revenue Consensus
    $411000
    Range$144000 - $773000
    4 analysts
    Dec 31, 2026
    EPS Consensus$-5.14
    Range$-6.24 - $-3.84
    4 analysts
    Revenue Consensus
    $479250
    Range$-160000 - $1M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-5.14---
    Sep 26EST
    		-$-1.70---
    Jun 26
    		$-0.19$-0.19+0.00%Beat+42.4%
    Mar 26
    		$-0.19$-0.17-11.76%Miss+44.1%
    Dec 25
    		$-2.20$-3.67+40.00%Beat-714.8%
    Sep 25
    		$-0.39$-0.26-50.00%Miss-14.7%
    Jun 25
    		$-0.33$-0.35+5.71%Beat+82.0%
    Mar 25
    		$-0.34$-0.33-3.03%Miss+78.9%
    Dec 24
    		$-0.27$-0.20-35.00%Miss+89.2%
    Sep 24
    		$-0.34$-0.44+22.73%Beat+87.9%
    Jun 24
    		$-1.83$-0.87-110.34%Miss+32.2%
    Mar 24
    		$-1.61$-2.00+19.50%Beat-631.8%
    Dec 23
    		$-2.50$-2.05-21.95%Miss-19.0%
    Sep 23
    		$-2.80$-2.40-16.67%Miss-12.0%
    Jun 23
    		$-2.70$-2.47-9.31%Miss+0.0%
    Mar 23
    		$-0.22$-0.21-4.76%Miss+87.1%
    Dec 22
    		$-2.10$-2.00-5.00%Miss-950.0%
    Sep 22
    		$-2.50$-2.20-13.64%Miss-900.0%
    Jun 22
    		$-2.70$-2.27-18.94%Miss-938.5%
    Mar 22
    		$-1.70$-2.25+24.44%Beat-844.4%
    Dec 21
    		$-0.20$-0.25+20.00%Beat-566.7%
    Sep 21
    		$-0.25N/AN/ABeat+62.0%
    Jun 21
    		$-0.26N/AN/ABeat-344.4%
    Mar 21
    		$-0.18N/AN/ABeat-136.5%
    Dec 20
    		$-0.03$0.00N/AMiss+87.1%
    Sep 20
    		$-0.66$0.00N/AMiss-
    Jun 20
    		$-0.06$0.00N/AMiss-
    Mar 20
    		$-0.08$0.00N/AMiss-
    Sep 19
    		$-0.23$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-2.32EV/EBITDA-49.61x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-2150.00%
    ROE-203.60%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.63xQuick Ratio2.63x
    Trading Statistics
    Beta-0.25Avg Volume613.01K
    52-Week High$12.3052-Week Low$4.75

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.55
    SMA 20$7.49
    SMA 50$6.99
    SMA 200$4.27
    EMA 10$7.25
    EMA 20$7.29
    EMA 50$7.14
    EMA 200$5.13

    MACD

    Line: 0.03Signal: 0.17Hist: -0.14

    ADX

    ADX: 37.7+DI: 7.6-DI: 0.3

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$0.91

    Bollinger Bands

    Upper Band$8.65
    Lower Band$6.33
    %B Position3093%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    45.8

    Momentum Oscillators

    Stoch %K92.8
    Stoch %D937.5
    Williams %R-6.0
    ROC (10d)-15.9%
    Momentum-1.30
    CCI (20d)224.0
    MFI (14d)63.6

    Volatility Measures

    ATR (14d)$5.49(79.6%)
    StdDev (20d)0.58
    Hist Vol102.1%(High)

    Volume Flow

    VWAP$6.90
    OBV234.8M
    AD Line10.4B
    CMF (20d)189.163

    Volume Metrics

    Avg Vol (20d)629.0K
    Vol Ratio0.2x(Low)
    VWMA (20d)$7.60

    Pivot Points

    R3$7.83
    R2$7.54
    R1$7.13
    Pivot Point$6.84
    S1$6.43
    S2$6.14
    S3$5.73

    Advanced Oscillators

    TSI1.58
    Ultimate Osc94.6
    KST137.02

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$287,000$398,000$365,000$137,000$316,000$381,000$603,000$773,000$468,000$548,000$63,000$150,000
    Cost of Revenue$105,000$134,000$108,000$12,000$170,000$106,000$74,000$91,000$124,000$219,000$65,000$96,000
    Gross Profit$182,000$264,000$257,000$125,000$146,000$275,000$529,000$682,000$344,000$329,000$-2,000$54,000
    Operating Expenses$6.35M$5.04M$5.66M$7.43M$5.54M$5.46M$4.81M$5.33M$3.84M$4.42M$5.44M$5.21M
    R&D$3.19M$2.32M$2.72M$3.85M$2.95M$2.52M$1.99M$2.21M$1.72M$2.22M$2.16M$1.84M
    SG&A$3.16M$2.72M$2.94M$3.58M$2.59M$2.94M$2.82M$3.13M$2.12M$2.20M$3.28M$3.37M
    Operating Income$-6,171,000$-4,775,000$-5,399,000$-7,310,000$-5,397,000$-5,181,000$-4,283,000$-4,649,000$-3,500,000$-4,090,000$-5,440,000$-5,161,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$45,000$0$0$0$0$0$0$0$181,000$0
    Income Before Tax$-6,073,000$-4,736,000$-5,444,000$-7,221,000$-5,028,000$-5,011,000$-4,083,000$-4,419,000$-3,413,000$-4,058,000$-5,621,000$-5,106,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,073,000$-4,736,000$-5,444,000$-7,221,000$-5,028,000$-5,011,000$-4,083,000$-4,419,000$-3,413,000$-4,058,000$-6,028,000$-5,106,000
    EBITDA$-5,852,000$-4,484,000$-5,166,000$-6,957,000$-4,765,000$-4,590,000$-3,841,000$-4,184,000$-3,184,000$-3,806,000$-5,385,000$-4,874,000
    EBIT$-6,073,000$-4,736,000$-5,444,000$-7,221,000$-5,028,000$-5,011,000$-4,083,000$-4,419,000$-3,413,000$-4,058,000$-5,621,000$-5,106,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LGVN

    News

    Longeveron Announces 1-for-10 Reverse Stock Split

    Longeveron Inc. (NASDAQ: LGVN) announced a 1-for-10 reverse stock split for its Class A and Class B common stock, effective August 26, 2026. This action is intended to increase the per-share trading price to meet Nasdaq's minimum bid price requirement for continued listing. CEO Stephen Willard stated that the split is a structural adjustment aimed at aligning the stock with institutional investor preferences and supporting compliance, without changing the company's capital strategy or operations.

    BioSpace•8/25/26•
    Somewhat-Bearish

    Longeveron (NASDAQ: LGVN) insider reports new stock dealings

    A recent SEC Form 4 filing indicates that Longeveron Inc. (NASDAQ: LGVN) director Soffer Rock has acquired 36,000 shares of Class A Common Stock through an award of time-based vesting Restricted Stock Units (RSUs). This transaction, dated August 19, 2026, resulted in a direct holding of 262,034 shares following the reported activity. The filing notes that the RSUs are subject to future vesting and that share amounts include Class B common stock which is convertible to Class A common stock and carries 5 votes per share.

    Stock Titan•8/22/26•
    Neutral

    Longeveron (NASDAQ: LGVN) insider logs new stock trades

    Longeveron Inc. (NASDAQ: LGVN) director Ursula Ungaro reported new stock trades in a Form 4 SEC filing. The filing indicates that Ungaro acquired 36,000 shares of Class A Common Stock, represented as Restricted Stock Units (RSUs) subject to future vesting. After the transaction, Ungaro's direct holdings amount to 77,000 shares of Class A Common Stock.

    Stock Titan•8/21/26•
    Neutral

    Longeveron (LGVN) grants director 36,000 stock units

    Longeveron Inc. (LGVN) director Deborah Ascheim was granted 36,000 shares of Class A Common Stock on August 19, 2026, through a grant/award of time-based vesting Restricted Stock Units (RSUs) at a price of $0.00 per share. This transaction increases her direct holdings to 36,000 shares, including RSUs subject to future vesting. The filing was categorized as an acquisition and was reported on a Form 4.

    Stock Titan•8/21/26•
    Neutral

    Longeveron (NASDAQ: LGVN) insider reports stock trades

    Longeveron Inc. (NASDAQ: LGVN) insider Joshua Hare, Chief Scientific Officer, has reported an acquisition of 286,000 shares of Class A Common Stock through a grant/award of time-based vesting Restricted Stock Units (RSUs) on August 19, 2026. This transaction increased his direct holdings to 1,607,796 shares, which includes both Class A and Class B common stock. The filing, a Form 4, indicates a neutral impact and sentiment according to Rhea-AI's analysis.

    Stock Titan•8/21/26•
    Neutral

    Frequently Asked Questions About LGVN

    Does LGVN pay dividends?
    Longeveron LLC (LGVN) does not currently pay a regular dividend.
    What is LGVN's market cap?
    Longeveron LLC (LGVN) has a market capitalization of $21.42M with a current stock price of $6.90.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In